Who Paid My Doc
Vasostrict
Drug Endocrinology
NDC 42023-164-25
General payments
$36,975
Research payments
$848,990
Through program year 2022, $36,975 in general payments and $848,990 in research payments were reported against Vasostrict (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $14,521 | 1 |
| 2021 | Research | $302,931 | 7 |
| 2020 | Research | $179,668 | 4 |
| 2019 | General | $36,975 | 2 |
| 2019 | Research | $351,869 | 2 |
Breakdown
Each share is of general payments naming this product in 2019.
Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2019 where a state was reported.
Records
2 general · 14 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.